ClinicalTrials.govpublic full text
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
stomach neoplasms, cik, gastric cancer, apatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 890216
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.